Mantle cell lymphoma (MCL) was preferentially sensitive to YM155 (P < 0.001), a cytotoxic agent with unclear mechanism of action reported to target survivin, Mcl-1 (31), and PI3K signaling (32). This evidence concerns the gene BIRC5 and mantle cell lymphoma.